Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nolitong is a traditional Chinese medicine (TCM) formulation developed as granules for the treatment of frequent episodic tension-type headache, specifically targeting the pattern of Qi and blood deficiency. Developed by Beijing Plantai Pharmaceutical Technology Development Co., Ltd., it has been evaluated in Phase 3 clinical trials in China to assess its efficacy and safety compared to placebo. As a TCM product, its therapeutic approach involves a multi-component botanical mixture intended to tonify Qi and nourish blood, thereby alleviating headache symptoms associated with these traditional diagnostic patterns. The formulation is administered orally and is designed to provide a standardized herbal treatment for patients suffering from chronic or frequent episodic tension-type headaches.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nolitong.